Relationship of Cannabis Use Disorder and Irritable Bowel Syndrome (IBS): An Analysis of 6.8 Million Hospitalizations in the United States

The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report

(2018) Donald I. Abrams   European Journal of Internal Medicine

Cannabinoids and gastrointestinal motility: Pharmacology, clinical effects, and potential therapeutics in humans

(2018) M. Camilleri   NEUROGASTROENTEROLOGY AND MOTILITY

Role of cannabis in digestive disorders

(2017) Hemant Goyal et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Irritable Bowel Syndrome

(2017) Alexander C. Ford et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Characteristics of Synthetic Cannabinoid Use in a Large Urban Psychiatric Emergency Setting

(2017) Marc W. Manseau et al.   SUBSTANCE USE & MISUSE

Evolution of the Cannabinoid and Terpene Content during the Growth of Cannabis sativa Plants from Different Chemotypes

(2016) Oier Aizpurua-Olaizola et al.   JOURNAL OF NATURAL PRODUCTS

Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition

(2016) Borwin Bandelow et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Gender-related differences in irritable bowel syndrome: Potential mechanisms of sex hormones

(2014) Mathieu Meleine   WORLD JOURNAL OF GASTROENTEROLOGY

The epidemiology of irritable bowel syndrome

(2014) Timothy Card et al.   Clinical Epidemiology

Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis

(2012) Rebecca M. Lovell et al.   Clinical Gastroenterology and Hepatology

Could gastrointestinal disorders differ in two close but divergent social environments?

(2012) Ewa Grodzinsky et al.   International Journal of Health Geographics

Pharmacogenetic Trial of a Cannabinoid Agonist Shows Reduced Fasting Colonic Motility in Patients With Nonconstipated Irritable Bowel Syndrome

(2011) Banny S. Wong et al.   GASTROENTEROLOGY

All-Cause Health Care Charges among Managed Care Patients with Constipation and Comorbid Irritable Bowel Syndrome

(2011) Debanjali Mitra et al.   POSTGRADUATE MEDICINE

The cannabinoid receptor agonist delta-9-tetrahydrocannabinol does not affect visceral sensitivity to rectal distension in healthy volunteers and IBS patients

(2010) T. K. Klooker et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS

(2010) P. Jerndal et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Cannabinoids and the gut: New developments and emerging concepts

(2010) Angelo A. Izzo et al.   PHARMACOLOGY & THERAPEUTICS

Prevalence and Risk Factors of Irritable Bowel Syndrome in Healthy Screenee Undergoing Colonoscopy and Laboratory Tests

(2010) Su Youn Nam et al.   Journal of Neurogastroenterology and Motility

Psychosocial Distress and Somatic Symptoms in Community Subjects With Irritable Bowel Syndrome: A Psychological Component Is the Rule

(2009) Rok Seon Choung et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Prevalence, bowel habit subtypes and medical care-seeking behaviour of patients with irritable bowel syndrome in Northern Greece

(2009) Panagiotis Katsinelos et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Factores sociosanitarios y prevalencia del síndrome del intestino irritable según los criterios diagnósticos de Roma III en una población general de Colombia

(2009) David Felipe Gómez Álvarez et al.   Gastroenterologia y Hepatologia

Childhood Trauma Is Associated With Hypothalamic-Pituitary-Adrenal Axis Responsiveness in Irritable Bowel Syndrome

(2009) Elizabeth J. Videlock et al.   GASTROENTEROLOGY

Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome

(2008) l. chang et al.   NEUROGASTROENTEROLOGY AND MOTILITY